Received Feb 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 2 | 944942 | IM / LA |
PATIENT RECEIVED THE SECOND DOSE OF THE VACCINE ON THE 25TH DAY INSTEAD OF THE REGULAR 30 DAYS AFTER FIRST DOSE. PATIENT HAS NO SYMPTOMS AND PATIENT CLAIMS TO BE IN PERFECT CONDITION
N/A
NO
N/A
NO KNOWN ALLERGIES
NONE